Emerging and High Growth Companies

Fusion Pharmaceuticals in its $212.5 million IPO

Fusion Pharmaceuticals
Team
Kelly O’Ferrall

Partner, Employment and Labour, Ottawa

Lynne Lacoursière

Partner, Corporate, Toronto

Sahil Chopra

Associate, Emerging and High Growth Companies, Toronto

Michael Grantmyre

Partner, Emerging and High Growth Companies, Calgary

Chad Bayne

Partner, Emerging and High Growth Companies, Toronto

Timothy Hughes

Partner, Tax, Toronto

Desmond Lee

Partner, Corporate, Toronto

Andrew MacDougall

Partner, Corporate, Toronto

Jacqueline Code

Partner, Research, Toronto

 

On June 25, 2020, Fusion Pharmaceuticals announced the pricing of its initial public offering of 12,500,000 common shares at a public offering price of $17.00 per share. All of the shares are being offered by Fusion. The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Fusion, are expected to be $212.5 million.

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines. Employing a proprietary Fast-Clear linker technology, Fusion connects alpha particle emitting isotopes to antibodies and other targeting molecules in order to selectively deliver the alpha emitting payloads to tumors.

Osler, Hoskin & Harcourt LLP advised Fusion Pharmaceuticals with a team consisting of Chad Bayne, Michael Grantmyre and Sahil Chopra (Emerging and High Growth Companies), Desmond Lee and Amy Sigurdson (Capital Markets), Andrew MacDougall (Corporate and Governance), Lynne Lacoursière and Kelly O'Ferrall (Executive Compensation), Shari Cohen (Employment & Labour), Tim Hughes (Tax) and Jacqueline Code (Research).

Value
$212.5 million
Date Closed
June 1, 2020
Lead Office
Toronto
Team
Kelly O’Ferrall

Partner, Employment and Labour, Ottawa

Lynne Lacoursière

Partner, Corporate, Toronto

Sahil Chopra

Associate, Emerging and High Growth Companies, Toronto

Michael Grantmyre

Partner, Emerging and High Growth Companies, Calgary

Chad Bayne

Partner, Emerging and High Growth Companies, Toronto

Timothy Hughes

Partner, Tax, Toronto

Desmond Lee

Partner, Corporate, Toronto

Andrew MacDougall

Partner, Corporate, Toronto

Jacqueline Code

Partner, Research, Toronto